Related Experiment Video
Updated: Feb 25, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling
Leonardo Schirone1, Maurizio Forte2, Silvia Palmerio1,2
1Department of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.
Insights
This review details molecular mechanisms driving cardiac remodeling after myocardial infarction. Understanding these pathways is key to developing new heart failure treatments and reducing cardiac complications.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Pathophysiology
Background:
- Myocardial remodeling alters heart structure and function through processes like myocyte loss, hypertrophy, and fibrosis.
- Stimuli such as pressure/volume overload and chronic inflammation post-myocardial infarction initiate remodeling.
- Prolonged cardiac remodeling can lead to heart failure progression.
Purpose of the Study:
- To review molecular pathways involved in cardiac remodeling, focusing on myocardial infarction.
- To highlight the role of cell signaling in cardiac remodeling.
- To discuss gene therapy approaches for modulating cardiac remodeling mediators.
Main Methods:
- Literature review of molecular mechanisms in cardiac remodeling.
- Analysis of cell signaling networks.
- Discussion of gene therapy strategies.
Main Results:
- Cardiac remodeling involves complex signaling pathways including myocyte loss, hypertrophy, ECM alteration, fibrosis, autophagy defects, metabolic, and mitochondrial dysfunction.
- Myocardial infarction triggers chronic inflammation contributing to remodeling and heart failure.
- Gene therapy offers potential for modulating key mediators.
Conclusions:
- Understanding molecular mechanisms of cardiac remodeling is crucial for developing novel therapeutic strategies.
- Targeting cell signaling pathways may prevent heart failure progression and reduce cardiac complications.
- Gene therapy presents a promising avenue for treating cardiac remodeling.
Abstract:
Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction. Among the complex signaling network that characterizes myocardial remodeling, the distinct processes are myocyte loss, cardiac hypertrophy, alteration of extracellular matrix homeostasis, fibrosis, defective autophagy, metabolic abnormalities, and mitochondrial dysfunction. Several pathophysiological stimuli, such as pressure and volume overload, trigger the remodeling cascade, a process that initially confers protection to the heart as a compensatory mechanism. Yet chronic inflammation after myocardial infarction also leads to cardiac remodeling that, when prolonged, leads to heart failure progression. Here, we review the molecular pathways involved in cardiac remodeling, with particular emphasis on those associated with myocardial infarction. A better understanding of cell signaling involved in cardiac remodeling may support the development of new therapeutic strategies towards the treatment of heart failure and reduction of cardiac complications. We will also discuss data derived from gene therapy approaches for modulating key mediators of cardiac remodeling.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Cardiac Performance
Cardiomyopathy III: Hypertrophic Cardiomyopathy

